Skip to content
OpenCapital
Earnings
Screener
Charts
Portfolio
Pricing
Connect your AI
Get started
Toggle navigation menu
Spyre Therapeutics, Inc.
SYRE
Segment Reporting Other Item Amount
Segment Reporting Other Item Amount at other companies
Protagonist Therapeutics
PTGX
-$53K
+35.4%
Essential Utilities
WTRG
-$75K
+74.4%
Atmos Energy
ATO
$1.01B
-7.3%
SiTime Corporation
SITM
$71.86M
+26.2%
ConocoPhillips
COP
$7.22B
+6.1%
Cleveland-Cliffs
CLF
$2M
—
Segments
By segment
See full
Reportable Segment
-$2.14M
+53.8%
Other financials
Income statement
See full
Revenue
-
—
Operating income
-$45.6M
+14.8%
Net income
-$69.0M
-54.1%
EPS (diluted)
-$0.74
-23.3%
Balance sheet
See full
Cash & equivalents
$97.2M
+100%
Total debt
$4.3M
-9.6%
Total equity
$670.8M
+39.0%
Total assets
$764.0M
+34.1%
Cash flow
See full
Operating cash flow
-$57.4M
-40.0%
CapEx
-
—
Free cash flow
-$39.4M
-26.8%
Valuation
See full
Market cap
$7.67B
+307%
Profitability
See full
Operating margin
-39,428.9%
-49,795pp
Net margin
-52,939.7%
-61,871pp
FCF margin
-3,442.8%
-3,807pp
Returns & leverage
See full
Return on equity
-31.1%
-10.7pp
Debt / equity
0.1×
+0.1×
Current ratio
9×
+0.9×